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Background: Exhaled nitric oxide (eNO) is a marker of established airway inflammation in adults and children, but
conflicting results have been reported in preterm infants when postnatal eNO is measured during tidal breathing.
This study investigated the extent to which intubation and mechanical ventilation (MV) affect eNO and NO production
(V’NO) in preterm infants with and without bronchopulmonary dysplasia (BPD).
Patients and methods: A total of 176 very low birth weight (VLBW) infants (birth weight <1500 g), including 74 (42%)
with and 102 (58%) without BPD, were examined at a median postmenstrual age of 49 weeks. Of the 176 infants,
84 (48%) did not require MV, 47 (27%) required MV for <7 days and 45 (26%) required MV for ≥7 days. Exhaled NO
and tidal breathing parameters were measured in sleeping infants during tidal breathing, respiratory mechanics were
assessed by occlusion tests, and arterialized capillary blood gas was analyzed.
Results: eNO was significantly correlated with tidal breathing parameters, while V’NO was correlated with
growth parameters, including age and body length (p < 0.001 each). Infants who were intubated and received MV
for <7 days had significantly lower eNO (p < 0.01) and V’NO (p < 0.01) than non-ventilated infants. In contrast, eNO
and V’NO did not differ significantly in non-ventilated infants and those receiving MV for ≥7 days. Multivariate analysis
showed that independent on the duration of MV eNO (p = 0.003) and V’NO (p = 0.018) were significantly increased in
BPD infants comparable with the effects of intubation and MV on eNO (p = 0.002) and V’NO (p = 0.017).
Conclusions: Preterm infants with BPD show only weak postnatal increases in eNO and V’NO, but these changes
may be obscured by the distinct influences of breathing pattern and invasive respiratory support. This limits the
diagnostic value of postnatal eNO measurements in the follow-up of BPD infants.
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Chronic lung disease (CLD) of prematurity, also called
bronchopulmonary dysplasia (BPD), is the most com-
mon long-term pulmonary disease after preterm birth
and neonatal intensive care [1] with consequences for
later lung function [2-4]. Although inconsistent findings
have been reported, there is a consensus that prematur-
ity per se may make a more important contribution to* Correspondence: gerd.schmalisch@charite.de
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article, unless otherwise stated.impaired lung function than BPD [5-7]. Moreover, in a
recent study [8] we have shown that prematurity and
neonatal lung disease, followed by mechanical ventila-
tion (MV), are independently associated with impaired
postnatal lung function.
Bronchial hyperreactivity is common in former preterm
infants with BPD and is likely due to airway damage in
early infancy caused by intubation and MV [9,10]. Besides
arresting lung maturation, lung inflammation is a major
contributor to the pathogenesis of BPD. Since lung inflam-
mation may be caused primarily by oxygen and/or MV,tral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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exhaled nitric oxide (eNO), a marker of eosinophilic airway
inflammation in adults and older children [11]. However,
studies of postnatal eNO in BPD infants have yielded con-
flicting results, with some showing increased eNO in BPD
infants [12,13] and others showing no differences in infants
with and without BPD [14,15]. Moreover, unchanged or
even decreased eNO has been observed when former BPD
infants reached school age [16-19].
A possible explanation for these conflicting results
may be differences in patient populations, as well as dif-
ferences in equipment and measuring conditions [20].
NO concentration in exhaled air is highly air flow-
dependent and originates primarily in the nose and the
paranasal sinuses, with some also originating in the
lower part of the respiratory tract [21,22]. Therefore, in
adults and older children the measurement conditions
have been standardized [23]. Online-measurements of
eNO in spontaneously breathing newborns, however,
can only be performed during tidal breathing, with a face
mask that assesses mixed air from the nose and upper
airway; hence such measurements in newborns may be
affected by variations in breathing pattern and often an
eNO plateau is missing in the exhaled air. We hypothe-
sized that, in spontaneously breathing neonates, the
different determinants of eNO may account for dif-
ferences in eNO between BPD and non-BPD infants.
This study was therefore designed to investigate the
effects of breathing pattern and invasive respiratory
support during the first days of life on differences in




This retrospective study examined eNO concentrations
in 176 very low birth weight (VLBW) infants, defined as
birth weights <1500 g. Infants were assessed between
June 2009 and June 2013 during lung function testing
(LFT) as part of our routine follow-up care of preterm
infants. At the time of measurement, the median age of
the 176 infants was 49 postmenstrual weeks. Infants with
congenital diaphragmatic hernia, congenital heart disease,
neuromuscular disease, or thoracic wall deformities were
excluded. Included infants were classified into three groups
according to the degree of respiratory support during the
first days of life in the same manner as in a former follow-
up study [8]: 1) those without or with only a mild respira-
tory insufficiency who could be treated by non-invasive
techniques (non-ventilated infants); 2) those requiring
intubation and MV for <7 days; and 3) those requiring MV
for ≥7 days. INSURE (INtubation, SURfactant, Extubation)
[24] was not considered MV. Subjects were also clas-
sified as with or without BPD, with BPD defined as arequirement for supplemental oxygen at a postmenstrual
age of 36 weeks.
All parents provided written informed consent before
each LFT, and the Institutional Data Safety Committee
approved this study.
eNO measurements
eNO was measured during routine LFT in clinically
stable children who had no respiratory infections during
the 3 weeks preceding the tests. Prior to testing, body
weight was measured to the nearest 10 g (Seca, Hamburg,
Germany) and body length (crown to heel) to the nearest
5 mm.
After a temperature stabilization period of at least
30 min, all devices were calibrated before measurement
according to the manufacturers’ guidelines. Sleeping in-
fants were measured in a supine position with the neck
in a neutral position and supported by a neck roll. Sleep
was induced 15–30 min before LFT by oral administra-
tion of chloral hydrate (50 mg∙kg−1), since sedation was
necessary for more complex LFT [8]. A compliant sili-
con mask (Infant mask, size 1; Vital Signs Inc., Totowa,
NJ, USA) was tightly placed over the nose and mouth
of each subject.
An NO filter ensured that all infants inhaled NO-free
air. eNO and tidal breathing were measured using the
EXHALYZER D (EcoMedics AG, Duernten, Switzerland),
which measures lung function in infants, and the fast
chemiluminescence NO-analyzer CLD 88 (EcoMedics).
Since eNO is strongly flow dependent, the EXHALYZER
D also calculates NO production (V’NO) to consider dif-
ferent flow conditions [15]. eNO was measured during
the third quartile of expiration, since it showed the lowest
breath-to-breath variability [25,26]. V’NO was calculated
by multiplying V’ by steady-state eNO (V’NO = V’∙eNO).
Simultaneously, the following tidal breathing param-
eters were recorded: tidal volume (VT), respiratory rate
(RR), minute ventilation (V’E), expiratory time (te), the ratio
of time to peak tidal expiratory flow to expiratory time
(tptef/te), peak tidal inspiratory flow (PTIF), peak tidal
expiratory flow (PTEF), mean tidal inspiratory flow
(MTIF) and mean tidal expiratory flow (MTEF). Shortly
afterwards, respiratory mechanics (respiratory compli-
ance (Crs) and respiratory resistance (Rrs)) were mea-
sured by the single occlusion test using the same face
mask and a balloon shutter to achieve brief airway oc-
clusion at end-inspiration, as described [27]. Between 5
and 15 occlusions were performed and the mean of 5
valid measurements of Crs and Rrs reported. All mea-
surements were performed using the MasterScreen™
BabyBody (CareFusion, Höchberg, Germany). All tidal
breathing flow and volume parameters and Crs were di-
vided by body weight on the day of measurement to re-
duce inter-subject variability.
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at the end of the LFT (ABL800 FLEX, Radiometer,
Denmark). Heart rate and oxygen saturation were moni-
tored continuously during the LFT by a pulse oximeter
(N-200; Nellcor, Hayward, California, USA).
Statistical methods
Patient characteristics are reported as rates or as me-
dians and interquartile ranges (IQR). Gender-specific
birth weight z-scores were calculated using published
national reference data [28]. Data were compared among
the three ventilation groups by the chi-square test,
Fisher’s exact test or the Kruskal-Wallis rank test, as
appropriate. Lung function parameters of the three venti-
lation groups are reported as median (IQR) and the dif-
ferences among the three groups were tested by the
Kruskal-Wallis rank test with the Mann–Whitney test as
post-hoc test. The effect of gender, antenatal steroids and
surfactant treatment on eNO and V’NO was tested using
the Kruskal-Wallis test. The relationships of eNO and
V’NO with the anthropometric and lung function parame-
ters were assessed by Spearman rank order correlation
coefficients with Bonferroni correction for multiple cor-
relations. The effect of BPD and mechanical ventilation
on eNO and V’NO and their interactions were investi-
gated by two way analysis of variance (ANOVA), with an-
thropometric and tidal breathing parameters as covariates.
All statistical analyses were performed using Statgraphics
Centurion® software (Version 16.0, Statpoint Inc., Herndon,




eNO and V’NO were measured in 176 VLBW infants at a
median (IQR) postmenstrual age of 49.0 (45.6 - 54.4)
weeks. Of these infants, 74 (42%) formerly had BPD, and
92 (52%) had a severe respiratory insufficiency that re-
quired intubation and intermittent MV with a nasally
inserted endotracheal tube for at least 24 h. Of the venti-
lated infants, 47 (27%) required MV for <7 days and 45
(26%) for ≥7 days. The median (IQR) duration of MV
was 7 (1–14) days, and was significantly longer for BPD
than for non-BPD infants (10 (3 – 27) days vs. 2.5 (1 – 7.5)
days, p < 0.001).
Table 1 compares patient characteristics relative to the
duration of MV. At the time of measurement, there were
no statistically significant between-group differences in
chronological age, postmenstrual age, body weight, and
body length. Infants requiring MV were significantly
(p < 0.001) more immature, had a lower birth weight and
a higher incidence of surfactant administration. How-
ever, there were no statistically significant differences of
birth weight z-scores between the ventilation groups. Theincidence of BPD was higher in ventilated than in non-
ventilated infants. Only the incidence of fetal lung matur-
ation was similar in the ventilation groups.
Factors associated with eNO and V’NO
There were no statistically significant associations between
eNO and V’NO levels and gender, use of antenatal steroids,
or surfactant treatment. Despite the strong correlation be-
tween eNO and V’NO (r = 0.778, p < 0.001), factors associ-
ated with them differed markedly. Table 2 shows the
correlation of eNO and V’NO with age, anthropometric pa-
rameters at birth and at the time of measurement and
lung function parameters. After Bonferroni correction for
multiple correlations, eNO showed statistically significant
correlations only with tidal breathing parameters whereas
V’NO correlated significantly with growth parameters (age,
postmenstrual age, body length), respiratory rate and dur-
ation of expiration. Gestational age, birth weight and birth
weight z-scores failed to display a statistically significant
correlation with eNO and V’NO.
The correlations between eNO and mean and peak
(MTEF, PTEF) tidal expiratory flow were negative. Thus,
as expiratory flow increased, the eNO concentration de-
creased. In contrast, eNO increased with increasing ex-
piratory time.
NO production was positively correlated with age and
anthropometric parameters, indicating that V’NO in-
creased with growth. There were no statistically signi-
ficant correlations between V’NO and tidal breathing
parameters, except for a significant negative correlation
between V’NO and respiratory rate and a strong positive
correlation with the expiratory time (both p < 0.001).
Effect of intubation and mechanical ventilation on eNO
and V’NO
Table 3 shows the measured lung function parameters
in the three patient groups classified by duration of
MV. Of the tidal breathing parameters, only tidal vol-
ume showed a slight decrease (p = 0.034) and respira-
tory rate showed a slight increase in ventilated patients
(p = 0.045). The compliance of the ventilated infants was
also reduced, but differed significantly only between
non-ventilated infants and infants mechanically venti-
lated for ≥7 days. There was no significant difference in
respiratory resistance between the three patient groups.
Blood gases, however, differed significantly among the
three MV groups, with pO2 decreasing and pCO2 in-
creasing significantly as the duration of MV increased
(both p < 0.001).
Intubation and mechanical ventilation had different ef-
fects on eNO and V’NO. The largest differences were seen
in infants ventilated <7 days, where eNO and V’NO were
significantly reduced (p < 0.01). In contrast, results were
similar in long-term ventilated and non-ventilated infants.
Table 1 Patient characteristics in the neonatal period and at the time of measurement according to the duration of
mechanical ventilation, presented as median and interquartile range (in brackets) or N (%)
Not ventilated infants Intubated and ventilated < 7days Intubated and ventilated ≥ 7days p-value
N = 84 N = 47 N = 45
Neonatal period
Gestational age (weeks) 29 27 26 <0.001
(28–30) (26 – 28) (25 – 27)
Birth weight (g) 1145 930 803 <0.001
(890–1340) (740–1230) (580 – 950)
Birth weight z-score −0.33 −0.14 −0.44 0.305
(−0.99 - 0.33) (−0.88 - 0.56) (−1.18 - 0.14)
Antenatal steroids1) 59/81 (73%) 33/42 (79%) 41/45 (91%) 0.053
Surfactant administration1) 41/83 (49%) 43/43 (100%) 42/45 (93%) <0.001
BPD 14 (17%) 25 (53%) 35 (78%) <0.001
At day of measurement
Age (days) 149 142 158 0.105
(116–204) (116 – 166) (143 – 181)
Postmenstrual age (weeks) 49.9 48.4 48.3 0.114
(46.9 – 58.0) (44.0 – 51.3) (46.4 – 53.4)
Body length (cm) 57.75 57 56.0 0.155
(55.0 – 62.3) (53 – 60.0) (54–60.0)
Body weight (g) 5052.5 4900 4815 0.210
(4315–6205) (4200 – 5860) (4100 – 5580)
1)Reduced total number due to incomplete data of patients examined by LFT.
Data represent median and interquartile range (in brackets) or N (%). Statistically significant p-values are printed in bold.
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To consider the dependency of eNO and V’NO on MV
duration, the effect of BPD on both parameters was
investigated by two way ANOVA, after adjustments
for age, body length, expiratory time te and MTEF. As
shown in Figure 1, both BPD and the duration of MV
had significant effects on eNO, with a lesser effect on
V’NO. Despite different levels in all ventilation groups,
mean eNO and V’NO were higher in BPD than in non-
BPD infants.
Multivariate analysis showed that the tidal breathing
parameters te and MTEF were significantly associated
with eNO, whereas anthropometric measures were not.
V’NO was significantly affected only by chronological
age. BPD and MV had no interactive effects on eNO and
V’NO (all p-values >0.1).
Discussion
The results presented here demonstrate that, in very
premature infants, BPD and intubation and MV due to
severe respiratory insufficiency affect eNO and V’NO
independently and in different directions. The mea-
sured median (IQR) eNO in non-ventilated infants
without BPD (10.0 (6.3 - 13.6) ppb) was slightly lower
than reference values published by Fuchs et al. [29](14 (10.7–17.4) ppb) using the same equipment measured
in unsedated term-born healthy infants at 5 weeks of age.
In our study, infants with previous BPD showed weak but
statistically significant increases in eNO and V’NO,
whereas intubation and MV for <7 days decreased both
parameters and did so to a greater degree. Thus, eNO
may be lower in a short term ventilated BPD infant than
in a non-ventilated infant without BPD. This hampers
the clinical interpretation of postnatal eNO and V’NO
and can lead to conflicting results, as shown in recent
studies measuring postnatal eNO in infants with and
without chronic lung disease (CLD) or BPD.
Leipala et al. [13] examined infants with chronic lung
disease (CLD) using tidal breathing measurements with
a face mask at 36–45 weeks post-conception. They found
higher peak nasal (p = 0.011) and facemask (p = 0.034)
NO levels in CLD than in non-CLD infants, in agreement
with our findings of weakly but significantly raised eNO
in BPD infants. May et al. [12] found also elevated eNO
in very premature intubated infants during MV on day
28 after birth, particularly in infants developing moderate
or severe BPD [12]. However, Wiliams et al. [30] have
shown that eNO during the first 4 weeks of life did not
differ significantly in groups of infants with and without
CLD, indicating that, in contrast to conventional LFT
Table 2 Spearman rank order coefficients of eNO and
V’NO with patient characteristics at birth and at day of
measurements and lung function parameters
eNO (ppb) V’NO (nL/s)
Rs p-value Rs p-value
Patient data at day of birth
Gestational age (weeks) −0.103 0.176 −0.058 0.447
Birth weight (g) −0.105 0.167 −0.045 0.555
Birth weight Z-score 0.033 0.666 0.049 0.515
Patient data at day of measurement
Age (days) 0.031 0.682 0.264 <0.001
PMA (weeks) −0.007 0.926 0.237 0.002
Body weight (g) −0.033 0.655 0.210 0.006
Body length (cm) 0.002 0.985 0.250 0.001
Tidal breathing
VT (mL/kg) 0.011 0.883 0.151 0.047
RR (1/min) −0.216 0.004 −0.266 <0.001
V’E (mL/min/kg) −0.228 0.003 −0.170 0.025
tptef/te (%) −0.110 0.148 −0.113 0.135
te (s) 0.274 <0.001 0.281 <0.001
PTIF (mL/s/kg) −0.062 0.415 −0.083 0.272
PTEF (mL/s/kg) −0.230 0.002 −0.163 0.032
MTIF (mL/s/kg) −0.121 0.112 −0.107 0.158
MTEF (mL/s/kg) −0.274 <0.001 −0.192 0.011
Respiratory mechanics
Crs (mL/kPa/kg) −0.027 0.725 0.058 0.450
Rrs (kPa/L/s) 0.078 0.318 −0.162 0.037
Blood gas analysis
paO2 (mmHg) −0.059 0.434 0.147 0.053
paCO2 (mmHg) 0.158 0.037 −0.037 0.628
Rs, Spearman rank order correlation coefficient, statistically significant values
after Bonferroni correction (p < 0.0025) are shown in boldface.
Abbreviations: PMA - postmenstrual age, VT - tidal volume, RR - respiratory rate, V’E-
minute ventilation, tptef/te - ratio of time to peak tidal expiratory flow to expiratory
time, te - expiratory time, PTIF - peak tidal inspiratory flow, PTEF - peak tidal
expiratory flow, MTIF - mean tidal inspiratory flow, MTEF - mean tidal expiratory
flow, Crs - respiratory compliance, Rrs - respiratory resistance.
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acity), eNO measurements during the first weeks of life
are not useful for predicting CLD and that eNO levels
may be raised only in infants with established BPD and
ongoing inflammation [30]. In contrast to the previous
studies Roiha et al. [15], measuring eNO and V’NO dur-
ing tidal breathing in 39 unsedated pre-term infants with
CLD (mean gestational age 27.3 weeks), found no statisti-
cally significant differences to term infants (39.9 weeks).
Following adjustment of eNO and V’NO for ventilatory
parameters, V’NO was slightly decreased in CLD in-
fants (p = 0.024). In that study the median (range) dur-
ation of intubation and MV was 1 (0–63) days, indicating
that most CLD infants received MV for only a short time.It remains unclear whether this may have influenced the
results in the same way as in the present study.
It also remains unclear why eNO and V’NO are re-
duced in short-term ventilated preterm infants. Nasal
intubation and MV may induce ciliary dyskinesia, char-
acterized by reduced eNO [22,31,32]. This would be on
accordance with the findings of Baraldi et al. [19]. In this
study eNO was reduced in school aged children who
formerly had CLD [19]. They speculated that an im-
paired NO synthesis and/or diffusion in the airways
could be a sequela of epithelial damage during the early
phases of BPD. Filiponne et al. [16] have shown that
children born prematurely with and without BPD have
increase oxidative stress compared to children born at
term despite normal eNO levels, pointing to other in-
flammatory pathways that cannot be picked up by eNO
measurements. Ricciardlo et al. [33] investigated deter-
minants of eNO in childhood atopic asthma. They found
that neonatal respiratory distress has been associated
with low eNO in children with atopic asthma [33]. The
higher eNO and V’NO in long-term (≥7 days) than in
short-term (<7 days) ventilated infants may have been
caused by established ongoing inflammation secondary
to prolonged intubation and mechanical ventilation as
well as exposure to supplemental oxygen [34].
We previously showed that, in preterm infants, intub-
ation and MV were mainly associated with increased
tissue and airway resistances, reduced effective lung vol-
ume and impaired blood gases [8]. However, we could
not determine whether these changes were caused by in-
tubation and MV or by the underlying respiratory dis-
ease. In the present study, we showed that intubation
and MV due to neonatal lung diseases also affected eNO
and V’NO, although these effects depended on the dur-
ation of MV. Because infants with acute respiratory tract
infection were excluded from the study, these effects on
eNO were negligible [29]. Except for tidal breathing and
anthropometric parameters, we could not find further
associations with eNO and V’NO levels, including data at
birth. Unfortunately, in this study we had no verified ac-
cess to data on maternal atopic disease [35], prenatal to-
bacco exposure [25,26] or traffic-related air pollution
[36,37] and thus could not investigate the impact of
these confounders on exhaled NO.
Ideally, eNO should be measured while the subject is
breathing out at a constant expiratory flow rate to obtain
an eNO plateau. Adults and older children exhale at a
constant flow (V’) against a resistance, resulting in a
plateau in the eNO signal [38]. However, this is not pos-
sible during postnatal tidal breathing. eNO measured
during the third quartile of expiration should mimic the
conditions of flow standardization in adults [25]. How-
ever, a higher respiratory rate and a shorter expiratory
time increase the likelihood that an eNO plateau will
Table 3 Lung function test results in VLBW infants according to the duration of mechanical ventilation
Not ventilated infants Intubated and ventilated < 7days Intubated and ventilated ≥ 7days p-value
N = 84 N = 47 N = 45
Tidal breathing
VT (mL/kg) 8.61 8.01 7.68** 0.034
(7.37 - 9.80) (6.70 - 9.67) (6.96 - 8.64)
RR (1/min) 40.9 44.8 44.4* 0.045
(36.0 - 47.1) (35.5 - 56.1) (38.0 - 55.7)
V’E (mL/min/kg) 346.2 373.0 353.0 0.452
(297.8 - 398.4) (311.2 - 407.3) (299.0 - 402.7)
tptef/te (%) 20.7% 22.1% 21.1% 0.898
(17.4% - 26.2%) (16.3% - 27.0%) (17.1% - 27.2%)
te (s) 0.857 0.770 0.753* 0.025
(0.720 - 0.962) (0.593 - 0.990) (0.577 - 0.861)
PTIF (mL/s/kg) 18.9 19.6 18.0 0.351
(15.4 - 21.3) (16.6 - 22.6) (16.4 - 20.7)
PTEF (mL/s/kg) 17.1 18.0 17.9 0.150
(14.6 - 19.4) (15.2 - 22.0) (14.5 - 20.9)
MTIF (mL/s/kg) 13.4 14.0 13.1 0.642
(11.5 - 15.4) (12.0 - 16.3) (11.8 - 15.7)
MTEF (mL/s/kg) 10.0 11.1 10.4 0.375
(8.6 - 12.0) (9.3 - 12.5) (8.9 - 13.0)
Respiratory mechanics
Crs (mL/kPa/kg) 10.6 9.2 8.9*** 0.002
(9.0 - 11.0) (7.6 - 11.6) (6.7 - 10.5)
Rrs (kPa/L/s) 5.96 6.55 6.15 0.094
(4.61 - 7.30) (5.07 - 8.62) (5.17 - 7.86)
Exhalation gas analysis
eNO (ppb) 10.0 6.6** 10.4 0.005
(6.3 - 13.6) (4.2 - 10.7) (7.2 - 13.8)
V’NO (nL/s) 0.50 0.39** 0.54 0.005
(0.34 - 0.72) (0.24 - 0.54) (0.37 - 0.66)
Blood gas analysis
paO2 (mmHg) 73.3 66.6* 65.6*** < 0.001
(65.5 - 83.0) (58.6 - 78.0) (58.5 - 70.9)
paCO2 (mmHg) 39.9 42.2* 44.6*** < 0.001
(37.7 - 43.7) (39.1 - 45.8) (41.1 - 47.3)
*p < 0.05, ** p < 0.01, *** p < 0.001 when compared to not ventilated infants. Data represent median (interquartile range). Statistically significant values are printed
in bold.
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graphic measurements in small lungs [39], especially at
appearance of air leaks [40]. The lack of a plateau in ex-
haled NO can lead to underestimations of eNO and
V’NO and may contribute to the negative correlations be-
tween these parameters and respiratory rate and the
positive correlations with expiratory time.
Therefore, a numerical adjustment of the measured
eNO and V’NO is recommended in comparative studies
[12] considering the differences in development andbreathing pattern [41,42]. Any such numerical adjust-
ment, however, can only be useful if eNO and V’NO are
measured equally accurately across the range of re-
spiratory rates of the sample. Using the measurement
equipment available today, the reliability of eNO and
V’NO measurements in preterm infants is limited by
the response time of the NO-analyzer. The strong de-
crease of V’NO with increasing respiratory rate (Table 2)
may be caused by this technical problem arising when
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Figure 1 Effect of BPD and the duration of mechanical ventilation on the exhaled NO (top) and the NO production (bottom). The p-values
show the extent of statistical significance of the covariates mean tidal expiratory flow (pMTEF), expiratory time (pTE), age (pAge) and body length (pBL);
those of the main effects by mechanical ventilation (pMV) and BPD (pBPD); and that of the interaction (pAB) of both factors. Statistically significant values
are shown in bold.
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studies.
This study has several strengths and limitations. The
main strengths include the use of a large sample size
classified by duration of MV and the use of the same in-
vestigator, equipment, and protocol for all patients, since
measurements of lung function in infants of this age are
highly dependent on device and protocol. The study lim-
itations include its retrospective design and the lack
of a control group of healthy infants [43]. Because
this study was retrospective, important maternal (e.g.,
smoking, atopy, asthma, education), neonatal (e.g., birth
characteristics, resuscitation management, postnatal ste-
roids, infections) and environmental parameters (e.g.,
smoking exposure, air pollution) which may affect thepostnatal lung development [44,45] were unavailable.
Further clinical data (e.g., the duration of non-invasive
respiratory support or oxygen treatment) may help to
understand the pathophysiology underlying this condition.
Furthermore, the extreme skewness in the patient distribu-
tion (there were only 10 long-term ventilated infants with-
out BPD) limits the number of parameters for multivariate
modeling.
Conclusion
Online tidal breathing measurements of eNO and V’NO
via a face mask are a simple and noninvasive technique
for assessing postnatal lung function. The inability to
standardize measurement conditions during tidal breath-
ing can result in a high dependency of measured
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http://www.biomedcentral.com/1756-0500/7/389parameters on breathing patterns. Although mean eNO
and V’NO are increased in BPD infants, these increases
are only weak and may be obscured by other factors af-
fecting eNO during tidal breathing. Thus the interpret-
ation of individual measurements is difficult due to
opposing influencing factors, making eNO and V’NO un-
likely to be helpful in following up BPD infants during
the first months of life.
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